![Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study - The Lancet Infectious Diseases Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/77cb3399-c58e-406c-985d-7a98efac872e/gr1_lrg.jpg)
Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study - The Lancet Infectious Diseases
![BA.2: What to know about world's dominant Omicron sub-variant | Coronavirus pandemic News | Al Jazeera BA.2: What to know about world's dominant Omicron sub-variant | Coronavirus pandemic News | Al Jazeera](https://www.aljazeera.com/wp-content/uploads/2022/03/AP20076669751772.jpg?resize=1800%2C1800)
BA.2: What to know about world's dominant Omicron sub-variant | Coronavirus pandemic News | Al Jazeera
![Effectiveness of previous infection-induced and vaccine-induced protection against hospitalisation due to omicron BA subvariants in older adults: a test-negative, case-control study in Quebec, Canada - The Lancet Healthy Longevity Effectiveness of previous infection-induced and vaccine-induced protection against hospitalisation due to omicron BA subvariants in older adults: a test-negative, case-control study in Quebec, Canada - The Lancet Healthy Longevity](https://www.thelancet.com/cms/asset/32aefdbc-6285-43ed-b04d-6d0af65aef62/gr1.jpg)
Effectiveness of previous infection-induced and vaccine-induced protection against hospitalisation due to omicron BA subvariants in older adults: a test-negative, case-control study in Quebec, Canada - The Lancet Healthy Longevity
![Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population | Nature Medicine Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-023-02219-5/MediaObjects/41591_2023_2219_Fig1_HTML.png)
Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population | Nature Medicine
![Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study - The Lancet Infectious Diseases Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/94b3e949-3582-4fef-b72c-84feb706af03/gr1_lrg.jpg)
Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study - The Lancet Infectious Diseases
![Canada: First case of highly mutated Omicron COVID variant BA.2.86 detected in British Columbia | Mint Canada: First case of highly mutated Omicron COVID variant BA.2.86 detected in British Columbia | Mint](https://www.livemint.com/lm-img/img/2023/08/30/1600x900/omicron_more_lethal_than_seasonal_flu_1646291062982_1693368064263.jpg)
Canada: First case of highly mutated Omicron COVID variant BA.2.86 detected in British Columbia | Mint
![BA.2 in Canada: Tam says officials are watching new Omicron subvariant 'very closely' - National | Globalnews.ca BA.2 in Canada: Tam says officials are watching new Omicron subvariant 'very closely' - National | Globalnews.ca](https://i0.wp.com/media.globalnews.ca/videostatic/news/z0b6p1012y-c1m5hx69v4/FRI_TAM_BA2_VARIANT_SITE_THUMB_280122.jpg?w=1040&quality=70&strip=all)
BA.2 in Canada: Tam says officials are watching new Omicron subvariant 'very closely' - National | Globalnews.ca
![Canada's CPHO on X: "1/3 #COVID19 key concerns 🇨🇦: disease activity is still high in Canada and the BA.2 sub-lineage now accounts for more than 90% of sequenced variants. https://t.co/h8xYW5cUh5 https://t.co/GhPLAAW2UW" / Canada's CPHO on X: "1/3 #COVID19 key concerns 🇨🇦: disease activity is still high in Canada and the BA.2 sub-lineage now accounts for more than 90% of sequenced variants. https://t.co/h8xYW5cUh5 https://t.co/GhPLAAW2UW" /](https://pbs.twimg.com/media/FRxnYQPWUAAdix3.jpg)
Canada's CPHO on X: "1/3 #COVID19 key concerns 🇨🇦: disease activity is still high in Canada and the BA.2 sub-lineage now accounts for more than 90% of sequenced variants. https://t.co/h8xYW5cUh5 https://t.co/GhPLAAW2UW" /
![Omicron subvariant BA.2 raises new questions about puzzling evolution of virus behind COVID-19 | CBC News Omicron subvariant BA.2 raises new questions about puzzling evolution of virus behind COVID-19 | CBC News](https://i.cbc.ca/1.6327447.1649186104!/fileImage/httpImage/image.jpg_gen/derivatives/16x9_780/omicron-close-ups.jpg)
Omicron subvariant BA.2 raises new questions about puzzling evolution of virus behind COVID-19 | CBC News
![An Imported Case of BA.2 Lineage of Omicron Variant COVID-19 — Guangdong Province, China, December 28, 2021 An Imported Case of BA.2 Lineage of Omicron Variant COVID-19 — Guangdong Province, China, December 28, 2021](https://weekly.chinacdc.cn/fileCCDCW/journal/article/ccdcw/2022/5/PIC/NoteOmiGuangdong2-1.jpg)